276 related articles for article (PubMed ID: 26690895)
1. Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders.
O'Farrell K; Harkin A
Neuropharmacology; 2017 Jan; 112(Pt B):307-323. PubMed ID: 26690895
[TBL] [Abstract][Full Text] [Related]
2. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
Fujigaki H; Yamamoto Y; Saito K
Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
[TBL] [Abstract][Full Text] [Related]
3. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
4. Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.
Notarangelo FM; Pocivavsek A
Neuropharmacology; 2017 Jan; 112(Pt B):275-285. PubMed ID: 26944732
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
Strasser B; Becker K; Fuchs D; Gostner JM
Neuropharmacology; 2017 Jan; 112(Pt B):286-296. PubMed ID: 26924709
[TBL] [Abstract][Full Text] [Related]
6. Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders.
Mor A; Tankiewicz-Kwedlo A; Krupa A; Pawlak D
Cells; 2021 Jun; 10(7):. PubMed ID: 34206739
[TBL] [Abstract][Full Text] [Related]
7. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ
Neuropharmacology; 2017 Jan; 112(Pt B):346-364. PubMed ID: 27265569
[TBL] [Abstract][Full Text] [Related]
8. The kynurenine pathway and the brain: Challenges, controversies and promises.
Schwarcz R; Stone TW
Neuropharmacology; 2017 Jan; 112(Pt B):237-247. PubMed ID: 27511838
[TBL] [Abstract][Full Text] [Related]
9. The kynurenine pathway and neurodegenerative disease.
Maddison DC; Giorgini F
Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway metabolites and enzymes involved in redox reactions.
González Esquivel D; Ramírez-Ortega D; Pineda B; Castro N; Ríos C; Pérez de la Cruz V
Neuropharmacology; 2017 Jan; 112(Pt B):331-345. PubMed ID: 26970015
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine pathway metabolites and suicidality.
Bryleva EY; Brundin L
Neuropharmacology; 2017 Jan; 112(Pt B):324-330. PubMed ID: 26820800
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine pathway metabolism and the microbiota-gut-brain axis.
Kennedy PJ; Cryan JF; Dinan TG; Clarke G
Neuropharmacology; 2017 Jan; 112(Pt B):399-412. PubMed ID: 27392632
[TBL] [Abstract][Full Text] [Related]
14. The kynurenine pathway and parasitic infections that affect CNS function.
Hunt NH; Too LK; Khaw LT; Guo J; Hee L; Mitchell AJ; Grau GE; Ball HJ
Neuropharmacology; 2017 Jan; 112(Pt B):389-398. PubMed ID: 26924710
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements.
Badawy AA
Neuropharmacology; 2017 Jan; 112(Pt B):248-263. PubMed ID: 26617070
[TBL] [Abstract][Full Text] [Related]
16. The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.
Cuartero MI; de la Parra J; García-Culebras A; Ballesteros I; Lizasoain I; Moro MÁ
Curr Pharm Des; 2016; 22(8):1060-73. PubMed ID: 25248805
[TBL] [Abstract][Full Text] [Related]
17. The Involvement of Kynurenine Pathway in Neurodegenerative Diseases.
Martins LB; Silveira ALM; Teixeira AL
Curr Neuropharmacol; 2023; 21(2):260-272. PubMed ID: 36154606
[TBL] [Abstract][Full Text] [Related]
18. The kynurenine pathway in schizophrenia and bipolar disorder.
Erhardt S; Schwieler L; Imbeault S; Engberg G
Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
[TBL] [Abstract][Full Text] [Related]
19. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids: Glutamatergic Transmission and Kynurenines.
Colín-González AL; Aguilera G; Santamaría A
Adv Neurobiol; 2016; 12():173-98. PubMed ID: 27651254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
